Samuel Adjei

Kwame Nkrumah University of Science and Technology, Ghana

SCHOLARLY PAPERS

1

DOWNLOADS

73

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Immunogenicity and Safety of Escherichia Coli-Produced Bivalent Human Papillomavirus Vaccine in Girls 9–14 Years of Age in Low- and Middle-Income Countries: Final Data of Randomized Controlled Trial

Number of pages: 34 Posted: 08 Nov 2024
Agogo Malaria Research Centre, PATH, Kwame Nkrumah University of Science and Technology, Ghana, PATH, PATH, Kwame Nkrumah University of Science and Technology, Ghana, International Vaccine Institute, International Centre for Diarrheal Disease Research (ICDDR’B), Government of the United States of America - HPV Serology Laboratory, PATH, Government of the United States of America - HPV Serology Laboratory, International Centre for Diarrheal Disease Research (ICDDR’B) - Infectious Disease Division, PATH, PATH and International Centre for Diarrheal Disease Research (ICDDR’B) - Infectious Diseases Division
Downloads 73 (658,483)

Abstract:

Loading...

Human papillomavirus (HPV), HPV vaccine, immunization, immunobridging, one-dose immunogenicity